Chinese researchers announced yesterday they had developed a vaccine for the H7N9 bird flu virus, after the flu strain had left more than 130 people infected, with 45 deaths reported.
Shu Yuelong, director of the Chinese National Influenza Center, said it is the first flu vaccine developed by Chinese scientists.
The vaccine has provided important technical support to battle the H7N9 flu virus epidemic control all over the world, said Shu, who is also director of the World Health Organization Collaborating Center for Reference and Research on Influenza.
It was jointly developed by the First Affiliated Hospital under the School of Medicine of Zhejiang University, Hong Kong University, Chinese Center for Disease Control and Prevention, National Institute for Food and Drug Control, and Chinese Academy of Medical Sciences.
China reported the world’s first human case for H7N9 bird flu infection in March. A total of 136 people have confirmed infected with the virus, according to the National Health and Family Planning Commission. Of these, 45 died, a 33 percent fatality rate.